CA2332270A1 - Cyclosporin preparations - Google Patents

Cyclosporin preparations Download PDF

Info

Publication number
CA2332270A1
CA2332270A1 CA002332270A CA2332270A CA2332270A1 CA 2332270 A1 CA2332270 A1 CA 2332270A1 CA 002332270 A CA002332270 A CA 002332270A CA 2332270 A CA2332270 A CA 2332270A CA 2332270 A1 CA2332270 A1 CA 2332270A1
Authority
CA
Canada
Prior art keywords
cyclosporin
preparation
solution
dry powder
gelatin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002332270A
Other languages
English (en)
French (fr)
Inventor
Robert Heger
Helmut Auweter
Peter Pfluger
Jorg Breitenbach
Rudolf Binder
Jurgen Zeidler
Gunther Berndl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2332270A1 publication Critical patent/CA2332270A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CA002332270A 1998-05-15 1999-05-04 Cyclosporin preparations Abandoned CA2332270A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19821951A DE19821951A1 (de) 1998-05-15 1998-05-15 Cyclosporin-Zubereitungen
DE19821951.2 1998-05-15
PCT/EP1999/003002 WO1999059541A2 (de) 1998-05-15 1999-05-04 Cyclosporin-zubereitungen

Publications (1)

Publication Number Publication Date
CA2332270A1 true CA2332270A1 (en) 1999-11-25

Family

ID=7867961

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002332270A Abandoned CA2332270A1 (en) 1998-05-15 1999-05-04 Cyclosporin preparations

Country Status (8)

Country Link
EP (1) EP1077676A2 (ja)
JP (1) JP2002515415A (ja)
CN (1) CN1301171A (ja)
AU (1) AU3930399A (ja)
CA (1) CA2332270A1 (ja)
DE (1) DE19821951A1 (ja)
NO (1) NO20005769D0 (ja)
WO (1) WO1999059541A2 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9920558D0 (en) * 1999-08-31 1999-11-03 Bradford Particle Design Ltd Methods for particle formation and their products
GB2381453A (en) * 1999-08-31 2003-05-07 Bradford Particle Design Ltd Active/polymer coformulations
US20020034525A1 (en) 2000-06-30 2002-03-21 Kao Corporation Skin cosmetic composition
EP2066309B1 (en) * 2007-04-04 2012-08-29 Sigmoid Pharma Limited An oral pharmaceutical composition
JP6627380B2 (ja) * 2015-09-30 2020-01-08 ユーハ味覚糖株式会社 アスコルビン酸もしくはアスコルビン酸誘導体の浸透性を向上させたナノ粒子分散液
CN106173799B (zh) * 2016-07-08 2019-08-16 武汉轻工大学 纳他霉素微乳液及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9201782A (es) * 1991-04-19 1992-10-01 Sandoz Ag Particulas de sustancias biologicamente activas, sustancialmente insolubles en agua, proceso para su produccion y composicion farmaceutica que las contiene.
ATE156350T1 (de) * 1992-01-17 1997-08-15 Alfatec Pharma Gmbh Peptidarzneistoffe enthaltende pellets und ihre herstellung sowie deren verwendung
RU2158601C2 (ru) * 1994-11-03 2000-11-10 Новартис Аг Новые лекарственные формы циклоспорина для орального применения с простым составом и высокой биодоступностью и способ их получения
KR100239799B1 (ko) * 1995-01-21 2000-02-01 손경식 경구투여용 사이클로스포린 에이 고체미셀분산체, 이의 제조 방법 및 고형제제
IE75744B1 (en) * 1995-04-03 1997-09-24 Elan Corp Plc Controlled release biodegradable micro- and nanospheres containing cyclosporin
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
DE19819273A1 (de) * 1998-04-30 1999-11-11 Pharmatec International S Giul Pharmazeutische Ciclosporin-Formulierung mit verbesserten biopharmazeutischen Eigenschaften, erhöhter physikalischer Qualität und Stabilität sowie Verfahren zur Herstellung

Also Published As

Publication number Publication date
WO1999059541A3 (de) 2000-01-20
JP2002515415A (ja) 2002-05-28
NO20005769L (no) 2000-11-14
AU3930399A (en) 1999-12-06
NO20005769D0 (no) 2000-11-14
CN1301171A (zh) 2001-06-27
WO1999059541A2 (de) 1999-11-25
EP1077676A2 (de) 2001-02-28
DE19821951A1 (de) 1999-11-18

Similar Documents

Publication Publication Date Title
AU754300B2 (en) Antifungal oral composition containing itraconazole and process for preparing same
US4540602A (en) Process for the preparation of activated pharmaceutical compositions
US8496968B2 (en) Method for production of microcapsules using solid fat
EP0988863B1 (en) Stable complexes of poorly soluble compounds
JP2001505928A (ja) シクロスポリン及び陰イオン性界面活性剤を含む固体医薬組成物
EP0702562A1 (en) Cyclosporin-containing powder composition
CA2365128A1 (en) Novel formulations comprising lipid-regulating agents
US20040180961A1 (en) Compositions and preparation methods for bioavailable oral aceclofenac dosage forms
JP2005513096A (ja) シクロスポリン、親水性界面活性剤及び親油性界面活性剤を含んで成る医薬組成物
US5968987A (en) Halofantrine free base for the treatment of malaria and compositions
EP2111854A1 (en) Self-microemulsifying systems incorporated into liquid core microcapsules
CA2332270A1 (en) Cyclosporin preparations
KR100679582B1 (ko) 경질 쉘 캡슐용 이부프로펜 용액
KR101767296B1 (ko) 활성제로서 페닐아미노피리미딘 유도체를 포함하는 제제
JPS63192719A (ja) 微細分散魚油製剤の製法
US20050181052A1 (en) Lansoprazole microtablets
JP2014162734A (ja) ペプチド含有ソフトカプセルの製造方法
EP3854384A1 (en) Pharmaceutical formulation comprising abiraterone acetate
JP2008521948A (ja) 難水溶性又は非水溶性の活性物質及び単細胞タンパク質物質の混合物の水性分散液、並びにそれから製造される乾燥粉末
GB2260080A (en) Gelled alginate compositions
CA2388614A1 (en) Pharmaceutical agent preparations
KR20000018902A (ko) 생체이용률이 증가된 이트라코나졸 함유 항진균용 조성물
KR20030000799A (ko) 난용성 항진균제의 경구투여용 조성물 및 이의 제조 방법
JP2000355552A (ja) オキサトミド製剤

Legal Events

Date Code Title Description
FZDE Dead